Clinical Trial Update: Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating budesonide orodispersible tablets for maintaining remission in eosinophilic esophagitis, comparing to placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• budesonide orodispersible tablets (budesonide)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: COMPLETED